S&P 500   4,254.73 (+0.60%)
DOW   33,105.40 (+0.31%)
QQQ   358.93 (+1.13%)
AAPL   173.17 (+0.45%)
MSFT   318.27 (+1.56%)
META   305.33 (+1.46%)
GOOGL   134.99 (+1.93%)
AMZN   126.41 (+1.36%)
TSLA   257.70 (+4.53%)
NVDA   438.28 (+0.71%)
NIO   8.75 (+1.63%)
BABA   84.16 (-0.45%)
AMD   102.28 (+2.20%)
T   14.60 (-1.22%)
F   12.05 (-0.17%)
MU   67.71 (-0.18%)
CGC   0.77 (+12.56%)
GE   109.19 (+1.33%)
DIS   79.51 (-0.04%)
AMC   8.06 (+2.68%)
PFE   33.61 (-0.86%)
PYPL   58.38 (+1.88%)
NFLX   378.09 (+0.36%)
S&P 500   4,254.73 (+0.60%)
DOW   33,105.40 (+0.31%)
QQQ   358.93 (+1.13%)
AAPL   173.17 (+0.45%)
MSFT   318.27 (+1.56%)
META   305.33 (+1.46%)
GOOGL   134.99 (+1.93%)
AMZN   126.41 (+1.36%)
TSLA   257.70 (+4.53%)
NVDA   438.28 (+0.71%)
NIO   8.75 (+1.63%)
BABA   84.16 (-0.45%)
AMD   102.28 (+2.20%)
T   14.60 (-1.22%)
F   12.05 (-0.17%)
MU   67.71 (-0.18%)
CGC   0.77 (+12.56%)
GE   109.19 (+1.33%)
DIS   79.51 (-0.04%)
AMC   8.06 (+2.68%)
PFE   33.61 (-0.86%)
PYPL   58.38 (+1.88%)
NFLX   378.09 (+0.36%)
S&P 500   4,254.73 (+0.60%)
DOW   33,105.40 (+0.31%)
QQQ   358.93 (+1.13%)
AAPL   173.17 (+0.45%)
MSFT   318.27 (+1.56%)
META   305.33 (+1.46%)
GOOGL   134.99 (+1.93%)
AMZN   126.41 (+1.36%)
TSLA   257.70 (+4.53%)
NVDA   438.28 (+0.71%)
NIO   8.75 (+1.63%)
BABA   84.16 (-0.45%)
AMD   102.28 (+2.20%)
T   14.60 (-1.22%)
F   12.05 (-0.17%)
MU   67.71 (-0.18%)
CGC   0.77 (+12.56%)
GE   109.19 (+1.33%)
DIS   79.51 (-0.04%)
AMC   8.06 (+2.68%)
PFE   33.61 (-0.86%)
PYPL   58.38 (+1.88%)
NFLX   378.09 (+0.36%)
S&P 500   4,254.73 (+0.60%)
DOW   33,105.40 (+0.31%)
QQQ   358.93 (+1.13%)
AAPL   173.17 (+0.45%)
MSFT   318.27 (+1.56%)
META   305.33 (+1.46%)
GOOGL   134.99 (+1.93%)
AMZN   126.41 (+1.36%)
TSLA   257.70 (+4.53%)
NVDA   438.28 (+0.71%)
NIO   8.75 (+1.63%)
BABA   84.16 (-0.45%)
AMD   102.28 (+2.20%)
T   14.60 (-1.22%)
F   12.05 (-0.17%)
MU   67.71 (-0.18%)
CGC   0.77 (+12.56%)
GE   109.19 (+1.33%)
DIS   79.51 (-0.04%)
AMC   8.06 (+2.68%)
PFE   33.61 (-0.86%)
PYPL   58.38 (+1.88%)
NFLX   378.09 (+0.36%)
NASDAQ:OSUR

OraSure Technologies (OSUR) Stock Forecast, Price & News

$5.91
0.00 (0.00%)
(As of 12:39 PM ET)
Compare
Today's Range
$5.85
$5.96
50-Day Range
$4.49
$6.91
52-Week Range
$3.56
$7.82
Volume
114,571 shs
Average Volume
605,712 shs
Market Capitalization
$433.91 million
P/E Ratio
10.19
Dividend Yield
N/A
Price Target
$5.00

OraSure Technologies MarketRank™ Forecast

Analyst Rating
0.00 Rating Score
Upside/​Downside
15.1% Downside
$5.00 Price Target
Short Interest
Healthy
3.31% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.09
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Decreasing
From $0.33 to ($0.31) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.63 out of 5 stars

Medical Sector

876th out of 965 stocks

Surgical & Medical Instruments Industry

91st out of 99 stocks


OSUR stock logo

About OraSure Technologies (NASDAQ:OSUR) Stock

OraSure Technologies, Inc., together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's diagnostic products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands for collecting genetic material from human saliva; Colli-Pee collection devices for the volumetric collection of void urine samples; and microbiome laboratory testing and analytical services. In addition, the company provides microbiome products, such as OMNIgene GUT for self-collecting microbial DNA from feces or stool samples for gut microbiome profiling; OMNIgene GUT DNA and RNA collection devices; and OMNIgeneGUT Dx collection device for collection of human fecal samples and the stabilization of DNA from the bacterial community. Additionally, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, disease risk management, diagnostics, pharmaceutical, biotech, nutrition, companion animal, and environmental markets. OraSure Technologies, Inc. was incorporated in 2000 and is based in Bethlehem, Pennsylvania.

OSUR Price History

OSUR Stock News Headlines

Is This Why OraSure Technologies, Inc. Is Tanking Today?
Better Than Oil Stocks
The best way to profit from energy is NOT a stock...Rather, it's this little-known alternative investment. 
J.P. Morgan Remains a Hold on Orasure Technologies (OSUR)
OraSure up 31% on Q3 revenue outlook, Q2 results
[BREAKING] Small Firm Wins $1 Billion Army Contract for Breakthrough "Living Software"
The Washington Post Reports it's: "A revolution in warfare." The Sunday Times Reports it's: "a revolutionary power." Early investors can reap 5,633% gains as England, Germany, Japan and Australia rush to sign contracts. Get the name of the stock here >>>
Q2 2023 OraSure Technologies Inc Earnings Call
Earnings Preview: OraSure Technologies
OraSure Technologies (NASDAQ: OSUR)
OSUR - OraSure Technologies, Inc.
Q1 2023 OraSure Technologies Inc Earnings Call
See More Headlines
Receive OSUR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter.

OSUR Company Calendar

Last Earnings
8/03/2023
Today
10/04/2023
Next Earnings (Estimated)
11/14/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:OSUR
CUSIP
68554V10
Employees
840
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$5.00
High Stock Price Forecast
$5.00
Low Stock Price Forecast
$5.00
Forecasted Upside/Downside
-15.0%
Consensus Rating
Rating Score (0-4)
0.00
Research Coverage
0 Analysts

Profitability

Net Income
$-17,930,000.00
Pretax Margin
8.61%

Debt

Sales & Book Value

Annual Sales
$387.48 million
Book Value
$5.01 per share

Miscellaneous

Free Float
71,800,000
Market Cap
$431.71 million
Optionable
Optionable
Beta
0.05
10 Best Stocks to Own in 2023 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2023 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Carrie Eglinton Manner (Age 48)
    Pres, CEO & Director
    Comp: $1.42M
  • Mr. Kenneth J. McGrath (Age 51)
    Chief Financial Officer
    Comp: $701.58k
  • Ms. Kathleen Gallagher Weber (Age 56)
    Chief Product Officer
    Comp: $890.87k
  • Ms. Michele Anthony (Age 48)
    Sr. VP, Chief Accounting Officer, Controller & Assistant Sec.
  • Mr. Rafal Iwasiow Ph.D.
    VP of Science, Innovation & Technology
  • Mr. Stefano Taucer
    Gen. Counsel & Corp. Sec.
  • Mr. David A. Rappaport C.F.A.
    CFA, Sr. VP Corp. Devel., Strategy & Integration
  • Amy Steigerwalt
    Sr. VP of HR
  • Mr. Zachary Wert
    Sr. VP of Global Operations
  • Ms. Trace Custer
    Sr. VP of Quality & Regulatory













OSUR Stock - Frequently Asked Questions

What is OraSure Technologies' stock price forecast for 2023?

0 brokers have issued 12 month target prices for OraSure Technologies' shares. Their OSUR share price forecasts range from $5.00 to $5.00. On average, they predict the company's stock price to reach $5.00 in the next year. This suggests that the stock has a possible downside of 15.0%.
View analysts price targets for OSUR
or view top-rated stocks among Wall Street analysts.

How have OSUR shares performed in 2023?

OraSure Technologies' stock was trading at $4.82 at the start of the year. Since then, OSUR shares have increased by 22.0% and is now trading at $5.88.
View the best growth stocks for 2023 here
.

When is OraSure Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, November 14th 2023.
View our OSUR earnings forecast
.

How were OraSure Technologies' earnings last quarter?

OraSure Technologies, Inc. (NASDAQ:OSUR) posted its earnings results on Thursday, August, 3rd. The medical instruments supplier reported ($0.07) earnings per share for the quarter, missing analysts' consensus estimates of ($0.06) by $0.01. The medical instruments supplier had revenue of $85.44 million for the quarter, compared to analysts' expectations of $64.30 million. OraSure Technologies had a net margin of 9.01% and a trailing twelve-month return on equity of 11.58%.

What ETF holds OraSure Technologies' stock ?

ETFMG Treatments Testing and Advancements ETF holds 20,685 shares of OSUR stock, representing 0.92% of its portfolio.

What guidance has OraSure Technologies issued on next quarter's earnings?

OraSure Technologies updated its third quarter 2023 earnings guidance on Friday, August, 4th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $72.00 million-$77.00 million, compared to the consensus revenue estimate of $48.91 million.

What is Stephen Tang's approval rating as OraSure Technologies' CEO?

2 employees have rated OraSure Technologies Chief Executive Officer Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among the company's employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OraSure Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI).

What is OraSure Technologies' stock symbol?

OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR."

How do I buy shares of OraSure Technologies?

Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OraSure Technologies' stock price today?

One share of OSUR stock can currently be purchased for approximately $5.88.

How much money does OraSure Technologies make?

OraSure Technologies (NASDAQ:OSUR) has a market capitalization of $431.71 million and generates $387.48 million in revenue each year. The medical instruments supplier earns $-17,930,000.00 in net income (profit) each year or $0.58 on an earnings per share basis.

How many employees does OraSure Technologies have?

The company employs 840 workers across the globe.

How can I contact OraSure Technologies?

OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The official website for the company is www.orasure.com. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at investorinfo@orasure.com, or via fax at 610-882-1830.

This page (NASDAQ:OSUR) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -